Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease
PROTEOMICS – Clinical Applications · 2021-05 · 15 (2-3)
DOI: 10.1002/prca.202000072 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 26.04.2021. Verfasst von Justin McKetney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Themen: Demenz
Abstract (Originalsprache)
Proteomic analysis of cerebrospinal fluid (CSF) holds great promise in understanding the progression of neurodegenerative diseases, including Alzheimer's disease (AD). As one of the primary reservoirs of neuronal biomolecules, CSF provides a window into the biochemical and cellular aspects of the neurological environment. CSF can be drawn from living participants allowing the potential alignment of clinical changes with these biochemical markers. Using cutting‐edge mass spectrometry technologies, we perform a streamlined proteomic analysis of CSF. We quantify greater than 700 proteins across 10 pairs of age‐ and sex‐matched participants in approximately one hour of analysis time each. Using the paired participant study structure, we identify a small group of biologically relevant proteins that show substantial changes in abundance between cognitive normal and AD participants, which were then analyzed at the peptide level using parallel reaction monitoring experiments. Our findings suggest the utility of fractionating a single sample and using matching to increase proteomic depth in cerebrospinal fluid, as well as the potential power of an expanded study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- National Center for Biology of Complex Systems, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Geriatric Research Education and Clinical Center, Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.
- Wisconsin Alzheimer's Institute, University of Wisconsin-Madison School of Medicine, Madison, Wisconsin, USA.
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine, Madison, Wisconsin, USA.
ORCID-Profile: Justin McKetney, Joshua J Coon
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
McKetney, J., Panyard, D. J., Johnson, S. C., Carlsson, C. M., Engelman, C. D., & Coon, J. J. (2021). Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease. PROTEOMICS – Clinical Applications, 15(2-3). https://doi.org/10.1002/prca.202000072
Vancouver
McKetney J, Panyard DJ, Johnson SC, Carlsson CM, Engelman CD, Coon JJ. Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease. PROTEOMICS – Clinical Applications. 2021;15(2-3). doi:10.1002/prca.202000072
BibTeX
@article{McKetney2021,
author = {McKetney, Justin and Panyard, Daniel J and Johnson, Sterling C and Carlsson, Cynthia M and Engelman, Corinne D and Coon, Joshua J},
title = {Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease},
journal = {PROTEOMICS – Clinical Applications},
year = {2021},
volume = {15},
number = {2-3},
doi = {10.1002/prca.202000072}
}
EUVIMED